241 related articles for article (PubMed ID: 32163206)
1. Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen-Sensing, Metabolism, and Dynamics.
Dasgupta A; Wu D; Tian L; Xiong PY; Dunham-Snary KJ; Chen KH; Alizadeh E; Motamed M; Potus F; Hindmarch CCT; Archer SL
Compr Physiol; 2020 Mar; 10(2):713-765. PubMed ID: 32163206
[TBL] [Abstract][Full Text] [Related]
2. Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.
Wu D; Dasgupta A; Read AD; Bentley RET; Motamed M; Chen KH; Al-Qazazi R; Mewburn JD; Dunham-Snary KJ; Alizadeh E; Tian L; Archer SL
Free Radic Biol Med; 2021 Jul; 170():150-178. PubMed ID: 33450375
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dynamics in pulmonary arterial hypertension.
Ryan J; Dasgupta A; Huston J; Chen KH; Archer SL
J Mol Med (Berl); 2015 Mar; 93(3):229-42. PubMed ID: 25672499
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer.
Archer SL; Gomberg-Maitland M; Maitland ML; Rich S; Garcia JG; Weir EK
Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H570-8. PubMed ID: 18083891
[TBL] [Abstract][Full Text] [Related]
5. Acquired Mitochondrial Abnormalities, Including Epigenetic Inhibition of Superoxide Dismutase 2, in Pulmonary Hypertension and Cancer: Therapeutic Implications.
Archer SL
Adv Exp Med Biol; 2016; 903():29-53. PubMed ID: 27343087
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
Hong Z; Chen KH; DasGupta A; Potus F; Dunham-Snary K; Bonnet S; Tian L; Fu J; Breuils-Bonnet S; Provencher S; Wu D; Mewburn J; Ormiston ML; Archer SL
Am J Respir Crit Care Med; 2017 Feb; 195(4):515-529. PubMed ID: 27648837
[TBL] [Abstract][Full Text] [Related]
7. Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension.
Breault NM; Wu D; Dasgupta A; Chen KH; Archer SL
Front Cell Dev Biol; 2023; 11():1105565. PubMed ID: 36819102
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension: A Pyruvate Dehydrogenase Kinase-Dependent Shift in Mitochondrial Metabolism Promotes Right Ventricular Fibrosis.
Tian L; Wu D; Dasgupta A; Chen KH; Mewburn J; Potus F; Lima PDA; Hong Z; Zhao YY; Hindmarch CCT; Kutty S; Provencher S; Bonnet S; Sutendra G; Archer SL
Circ Res; 2020 Jun; 126(12):1723-1745. PubMed ID: 32216531
[TBL] [Abstract][Full Text] [Related]
9. An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.
Bonnet S; Michelakis ED; Porter CJ; Andrade-Navarro MA; Thébaud B; Bonnet S; Haromy A; Harry G; Moudgil R; McMurtry MS; Weir EK; Archer SL
Circulation; 2006 Jun; 113(22):2630-41. PubMed ID: 16735674
[TBL] [Abstract][Full Text] [Related]
10. The role of k+ channels in determining pulmonary vascular tone, oxygen sensing, cell proliferation, and apoptosis: implications in hypoxic pulmonary vasoconstriction and pulmonary arterial hypertension.
Moudgil R; Michelakis ED; Archer SL
Microcirculation; 2006 Dec; 13(8):615-32. PubMed ID: 17085423
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension.
Dromparis P; Paulin R; Sutendra G; Qi AC; Bonnet S; Michelakis ED
Circ Res; 2013 Jul; 113(2):126-36. PubMed ID: 23652801
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cell energy metabolism, proliferation, and apoptosis in pulmonary hypertension.
Xu W; Erzurum SC
Compr Physiol; 2011 Jan; 1(1):357-72. PubMed ID: 23737177
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial HSP90 Accumulation Promotes Vascular Remodeling in Pulmonary Arterial Hypertension.
Boucherat O; Peterlini T; Bourgeois A; Nadeau V; Breuils-Bonnet S; Boilet-Molez S; Potus F; Meloche J; Chabot S; Lambert C; Tremblay E; Chae YC; Altieri DC; Sutendra G; Michelakis ED; Paulin R; Provencher S; Bonnet S
Am J Respir Crit Care Med; 2018 Jul; 198(1):90-103. PubMed ID: 29394093
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of mitochondrial fission prevents hypoxia-induced metabolic shift and cellular proliferation of pulmonary arterial smooth muscle cells.
Parra V; Bravo-Sagua R; Norambuena-Soto I; Hernández-Fuentes CP; Gómez-Contreras AG; Verdejo HE; Mellado R; Chiong M; Lavandero S; Castro PF
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2891-2903. PubMed ID: 28739174
[TBL] [Abstract][Full Text] [Related]
15. Reoxygenation Reverses Hypoxic Pulmonary Arterial Remodeling by Inducing Smooth Muscle Cell Apoptosis via Reactive Oxygen Species-Mediated Mitochondrial Dysfunction.
Chen J; Wang YX; Dong MQ; Zhang B; Luo Y; Niu W; Li ZC
J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28645933
[TBL] [Abstract][Full Text] [Related]
16. Constitutive Reprogramming of Fibroblast Mitochondrial Metabolism in Pulmonary Hypertension.
Plecitá-Hlavatá L; Tauber J; Li M; Zhang H; Flockton AR; Pullamsetti SS; Chelladurai P; D'Alessandro A; El Kasmi KC; Ježek P; Stenmark KR
Am J Respir Cell Mol Biol; 2016 Jul; 55(1):47-57. PubMed ID: 26699943
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial biogenesis: pharmacological approaches.
Valero T
Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary arterial hypertension: pathogenesis and clinical management.
Thenappan T; Ormiston ML; Ryan JJ; Archer SL
BMJ; 2018 Mar; 360():j5492. PubMed ID: 29540357
[TBL] [Abstract][Full Text] [Related]
19. Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.
Kurosawa R; Satoh K; Kikuchi N; Kikuchi H; Saigusa D; Al-Mamun ME; Siddique MAH; Omura J; Satoh T; Sunamura S; Nogi M; Numano K; Miyata S; Uruno A; Kano K; Matsumoto Y; Doi T; Aoki J; Oshima Y; Yamamoto M; Shimokawa H
Circ Res; 2019 Jul; 125(3):309-327. PubMed ID: 31195886
[TBL] [Abstract][Full Text] [Related]
20. The metabolic theory of pulmonary arterial hypertension.
Paulin R; Michelakis ED
Circ Res; 2014 Jun; 115(1):148-64. PubMed ID: 24951764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
